PAPER Si Q, Gan C, Shan A, Sun H, Cao X, Ye S, Shi J, Wan C, Wang X, Yuan Y, Zhang K

Cholinergic basal forebrain atrophy and cortical alterations in Parkinson's disease with apathy.

Parkinsonism Relat Disord. 2025 Mar 13;134:107793. Epub 2025 Mar 13 PubMed.

PAPER Fuller JL, Shi K, Pockes S, Finzel BC, Ashe KH, Walters MA

Reengineering of Circularly Permuted Caspase-2 to Enhance Enzyme Stability and Enable Crystallographic Studies.

ACS Chem Biol. 2025 Mar 21; Epub 2025 Mar 21 PubMed.

PAPER Wang Y, Wang Y, Xu Y, Cheng H, Dagnew TM, Kang L, Tocci D, Shen IZ, Zhang C, Wang C

Design and Development of a Novel BET Protein-Targeted PET Imaging Probe for In Vivo Characterization of Alzheimer's Disease Pathophysiology.

J Med Chem. 2025 Mar 21; Epub 2025 Mar 21 PubMed.

PAPER Koehn LM, Steele JR, Schittenhelm RB, Nicolazzo JA

Sex-Specific Markers of Neuroinflammation and Neurodegeneration in the Spinal Cord Proteome of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

J Proteome Res. 2025 Mar 21; Epub 2025 Mar 21 PubMed.

PAPER Sidhu RK, Maparu K, Singh S, Aran KR

Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons.

Pharmacol Rep. 2025 Mar 21; Epub 2025 Mar 21 PubMed.

PAPER Zhang X, Irish M, Piguet O, Ahmed RM

Behavioural and cognitive profiles in frontotemporal dementia and Alzheimer's disease: a longitudinal study.

J Neurol. 2025 Mar 21;272(4):279. PubMed.

PAPER Kraake S, Luppa M, Saur D, Dietzel J, Bach JP, Riedel-Heller SG, Stein J

Social functioning in individuals with Alzheimer's disease and the situation of caregivers.

J Alzheimers Dis. 2025 Mar 21;:13872877251326029. Epub 2025 Mar 21 PubMed.

PAPER Williams JP, Zhu Y, Singh RK, Beyene K, Rani R, Kapetanakos X, Dias A, McGuire K, Kolady R, Lipsey K, Ramaswamy SG, Thotakura V, Trani JF, Babulal GM

The effect of anti-seizure medications on Alzheimer's disease (AD) risk and AD-related symptoms: A scoping review.

J Alzheimers Dis. 2025 Mar 21;:13872877251324663. Epub 2025 Mar 21 PubMed.

PAPER MacIver MB, Pearce RA

Reduced GABAA, slow synaptic inhibition in Alzheimer's disease.

J Alzheimers Dis. 2025 Mar 21;:13872877251328940. Epub 2025 Mar 21 PubMed.

PAPER Abdullah L, Zhou Z, Hall J, Petersen M, Zhang F, O'Bryant S

Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.

J Alzheimers Dis. 2025 Mar 21;:13872877251322966. Epub 2025 Mar 21 PubMed.

PAPER Nataraj A, Blahna K, Ježek K

Insights From TgF344-AD, a Double Transgenic Rat Model in Alzheimer's Disease Research.

Physiol Res. 2025 Mar 21;74(1):1-17. PubMed.

PAPER Nakashima S, Sato K, Niimi Y, Toda T, Iwatsubo T

Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohort.

JAR Life. 2025;14:100008. Epub 2025 Mar 3 PubMed.

PAPER Zhang L, Santoni L, Ngo NA, Simayi R, Ficiará E, de Vivo L, Bellesi M

Rocking during sleep reduces motor deficits and beta-amyloid levels in an Alzheimer's mouse model.

iScience. 2025 Mar 21;28(3):112036. Epub 2025 Feb 15 PubMed.

PAPER Kumari A, Rahaman A, Zeng XA, Baloch Z

Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer's disease.

Mol Ther Nucleic Acids. 2025 Mar 11;36(1):102439. Epub 2024 Dec 23 PubMed.

PAPER Wolf T, Moss L, Hudson C, Winters AM, Abdelmaboud SS, Avlas M, Wohlfahrt J, Guergues J, Bickford PC, Stevens SM Jr

Chronic alcohol exposure during young adulthood attenuates microglial reactivity and downstream immune response pathways in a mouse model of tauopathy later in life.

Alcohol Clin Exp Res (Hoboken). 2025 Mar 21; Epub 2025 Mar 21 PubMed.